Alto Neuroscience ANRO SEC Filings

NYSE ANRO
$35.90 -0.50 (-1.37%)
As of: Sep 4, 2026 · 12:51 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Alto Neuroscience, Inc. (ANRO) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index